RTX Corp: Form 10-K for the period ended Dec 31, 2018
Filed with the SEC on Feb 7, 2019 and accepted by EDGAR at Feb 7, 2019, 06:40 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2018-10-01 to 2018-12-31 | $18.04bn | us-gaap:Revenues |
| Revenue | 12 months2018-01-01 to 2018-12-31 | $66.50bn | us-gaap:Revenues |
| Gross profit | 3 months2018-10-01 to 2018-12-31 | $4.30bn | us-gaap:GrossProfit |
| Research and development | 12 months2018-01-01 to 2018-12-31 | $2.46bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2018-01-01 to 2018-12-31 | $7.07bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2018-01-01 to 2018-12-31 | $8.55bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2018-01-01 to 2018-12-31 | $1.04bn | us-gaap:InterestExpense |
| Income tax | 12 months2018-01-01 to 2018-12-31 | $2.63bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2018-10-01 to 2018-12-31 | $686.0m | us-gaap:NetIncomeLoss |
| Net income | 12 months2018-01-01 to 2018-12-31 | $5.27bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2018-10-01 to 2018-12-31 | $0.83 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2018-01-01 to 2018-12-31 | $6.50 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2018-10-01 to 2018-12-31 | $0.83 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2018-01-01 to 2018-12-31 | $6.58 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2018-01-01 to 2018-12-31 | 810,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2018-01-01 to 2018-12-31 | $6.32bn | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 12 months2018-01-01 to 2018-12-31 | $1.90bn | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 12 months2018-01-01 to 2018-12-31 | $2.17bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2018-01-01 to 2018-12-31 | $325.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2018-12-31 | $6.15bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-12-31 | $35.50bn | us-gaap:AssetsCurrent |
| Total assets | At period end2018-12-31 | $134.21bn | us-gaap:Assets |
| Current liabilities | At period end2018-12-31 | $31.37bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2018-12-31 | $93.49bn | us-gaap:Liabilities |
| Long-term debt | At period end2018-12-31 | $44.07bn | us-gaap:LongTermDebt |
| Short-term borrowings | At period end2018-12-31 | $1.47bn | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2018-12-31 | $38.45bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000101829-19-000007. Last ingested by Listed: Nov 3, 2026, 21:25 ET. Listed shows no prices and gives no investment advice.